Semler Scientific (NASDAQ:SMLR) Shares Gap Down – What’s Next?

Semler Scientific, Inc. (NASDAQ:SMLR)’s share price gapped down prior to trading on Friday . The stock had previously closed at $61.15, but opened at $53.99. Semler Scientific shares last traded at $54.80, with a volume of 637,150 shares.

Analyst Ratings Changes

Separately, Lake Street Capital boosted their target price on shares of Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research note on Friday.

Semler Scientific Stock Performance

The business’s 50 day simple moving average is $59.91 and its 200-day simple moving average is $39.99. The company has a market cap of $508.92 million, a price-to-earnings ratio of 26.72 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last issued its earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.35. The company had revenue of $13.51 million for the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of SMLR. Newbridge Financial Services Group Inc. acquired a new position in Semler Scientific during the second quarter worth $34,000. Quest Partners LLC increased its holdings in shares of Semler Scientific by 48.0% during the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after acquiring an additional 817 shares during the last quarter. US Bancorp DE raised its stake in shares of Semler Scientific by 60.8% in the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after acquiring an additional 1,158 shares in the last quarter. Sanctuary Advisors LLC acquired a new stake in Semler Scientific in the 3rd quarter worth approximately $104,000. Finally, Rhumbline Advisers boosted its position in Semler Scientific by 27.1% during the second quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after purchasing an additional 1,320 shares during the period. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.